Sweet
Value
Lab
Methodology
Pricing
Allogene Therapeutics, Inc.
ALLO
Healthcare
Biotechnology
NASDAQ
Sign in to watch
$2.26
Market Cap: $550.94M
Valuation
Financials
Forecast
Compare
Historical Price
Solvency
Dividends
Transactions
People
Allogene Therapeutics, Inc. (ALLO) Analyst Estimates